Philips announces next-gen cardiovascular ultrasound platform to improve cardiac analysis. New FDA-cleared AI-enabled applications include the industry’s first automated tool for segmental wall motion scoring of the heart to quickly and objectively identify disorders including coronary artery disease and cardio-oncology issues in seconds.
Discussion
No replies yet.